Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Proper education can prevent traction alopecia in women of color.

Polyesters show promise for repairing damaged blood vessels.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Early treatment helps stop hair loss in women of color.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Methotrexate side effects vary by race and sex.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Hydroxychloroquine can help treat certain types of hair loss.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.